The Efficiency and Safety of Triple-Drug Combination of Albumin-Bound Paclitaxel, Anlotinib and PD-1/L1 Inhibitors in the 2nd or Above Line of Advanced NSCLC: A Retrospective Cohort Study
-
Published:2024-08
Issue:
Volume:Volume 16
Page:1003-1012
-
ISSN:1179-1322
-
Container-title:Cancer Management and Research
-
language:en
-
Short-container-title:CMAR
Author:
Li XiaobingORCID,
Wu De,
Tang Jing,
Wu Yuebing
Publisher
Informa UK Limited